Phase I and pharmacokinetic study of LY293111, an orally bioavailable LTB4 receptor antagonist, in patients with advanced solid tumors (Q81820052)
Jump to navigation
Jump to search
scientific article published on 06 June 2005
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase I and pharmacokinetic study of LY293111, an orally bioavailable LTB4 receptor antagonist, in patients with advanced solid tumors |
scientific article published on 06 June 2005 |
Statements
Phase I and pharmacokinetic study of LY293111, an orally bioavailable LTB4 receptor antagonist, in patients with advanced solid tumors (English)
Gary K Schwartz
Aaron Weitzman
Les Brail
Dinesh P de Alwis
Ann Cleverly
Barbara Barile-Thiem
Vincent Vinciguerra